Bank Of Montreal Protagonist Therapeutics, Inc Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$18.02 - $29.36 $5.59 Million - $9.1 Million	310,000 New	310,000 $8.56 Million
Q1 2022 May 12, 2022	SELL	$23.34 - $36.08 $499,476 - $772,112	-21,400 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$17.63 - $37.1 $7,140 - $15,025	-405 Reduced 1.86%	21,400 $734,000
Q3 2021 Nov 12, 2021	SELL	$12.95 - $49.69 $550,051 - $2.11 Million	-42,475 Reduced 66.08%	21,805 $385,000
Q2 2021 Aug 12, 2021	BUY	$25.57 - $44.88 $1.64 Million - $2.88 Million	64,280 New	64,280 $2.84 Million

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.